Webinars, Pharmaceutical

Advancements in Targeted Drug Delivery for Nasal and Pulmonary Devices

The field of drug delivery is witnessing a transformative era, particularly in the realm of nasal and pulmonary systems. A recent presentation titled “Advancements in Targeted Drug Delivery for Nasal and Pulmonary Devices” at Pharmapack 2024, shed light on the recent developments that are set to redefine how medications are administered for respiratory and systemic conditions. This comprehensive overview explores the key aspects of nasal drug delivery, nasal drug delivery systems, and targeted nasal drug delivery, highlighting the significant strides made towards optimizing the efficacy and precision of treatments.

A learning lab talk delivered by Eleanor Canipa, January 2024

Watch Advancements in Targeted Drug Delivery for Nasal and Pulmonary Devices Video
Speaker(s): Eleanor Canipa
5 Mar 2024

The Essence of Targeted Drug Delivery

Targeted drug delivery systems stand at the forefront of pharmaceutical innovation, aiming to revolutionize the way treatments are administered and experienced by patients. The primary goal is to enhance the precision with which drugs are delivered to specific areas within the body, thereby maximizing therapeutic effects while minimizing side effects. In the context of nasal and pulmonary drug delivery, this precision is paramount given the complex anatomy and the critical functions of the respiratory system.

The Role of the Drug Delivery System Design and Patient Anatomy

A key aspect discussed during the presentation was the influence of multiple factors on the regional deposition of drugs within the nasal cavity and lungs. It was emphasized that patient anatomy, formulation properties, and notably, the design and mechanics of the delivery device play pivotal roles in determining the effectiveness of drug delivery. The interaction between these factors can significantly impact where and how much of the drug is deposited, affecting both local and systemic therapeutic outcomes.

The presentation underscored the importance of understanding these dynamics to achieve targeted nasal drug delivery. It was noted that the unique anatomical structures of the nasal cavity and pulmonary system require specialized technology designs that can navigate these complexities to deposit drugs precisely where needed.

Innovations in Drug Delivery Design

Highlighting advancements in technologies, the presentation focused on new designs that promise to allow for more targeted deposition of drugs. These innovative devices are engineered to take into account the variability in patient anatomy and the specific requirements of different drug formulations. By doing so, they aim to optimize the delivery of medications directly to the intended site of action, enhancing the efficacy and reducing potential side effects.

Leveraging In Vitro Measurement and In Silico Modelling

Another significant advancement discussed was the use of in vitro measurement and in silico modelling tools. These tools represent a leap forward in the development and selection of nasal and pulmonary drug delivery systems. In vitro measurements provide empirical data on how drug delivery systems perform under controlled conditions, offering insights into their efficiency and deposition patterns. Meanwhile, in silico modelling offers a computational approach to predict how drug delivery systems and drugs will behave in a real-world scenario, taking into account the complexities of human anatomy and physiology.

The integration of these tools allows for a more informed decision-making process when selecting the appropriate device for a targeted indication. By simulating various conditions and analyzing outcomes, pharmaceutical companies can refine their devices to achieve optimal drug delivery.


The presentation “Advancements in Targeted Drug Delivery for Nasal and Pulmonary Devices” highlighted the multifaceted approach required to advance nasal and pulmonary drug delivery systems. Through innovations in device design, coupled with sophisticated in vitro and in silico tools, the pharmaceutical industry is poised to make significant strides towards more effective and targeted therapies.

As we move forward, these advancements promise to improve the quality of life for patients suffering from respiratory and systemic conditions by offering more precise, efficient, and tailored treatment options. The journey towards optimizing nasal drug delivery systems is ongoing, but the progress showcased in this presentation marks a promising step towards a future where targeted drug delivery becomes a cornerstone of therapeutic strategies.

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About Nasal Drug Delivery

Learn more about Aptar Pharma Expertise
in Inhalation Drug Delivery

Find Out More About inhalation drug delivery expertise

This Might Also Be of Interest

3 Apr 2024

Delivering Nasally Administered Biologics

Webinars, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Market Insights

Read More
3 Apr 2024

Nasal Casts, Tools to Enable Nasal Drug Delivery Development

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
26 Mar 2024

Optimizing Preclinical Studies for Intranasal and Pulmonary Programs

Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Device Innovations

Read More
13 Mar 2024

In Silico Modelling for Orally Inhaled Drug Development (OINDP)

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
1 2 3 33

Request Access


Requesting access to Advancements in Targeted Drug Delivery for Nasal and Pulmonary Devices.

  • This field is for validation purposes and should be left unchanged.
Back To Top